Moderna Inc
Stocks making the biggest moves premarket: Moderna, Alaska Air, Oxford Industries and more
Check out the companies making headlines before the bell: Alaska Air Group — Shares gained 5% after Alaska Air Group raised its third-quarter outlook, citing strong summer demand. The airline guided for per-share earnings in the range of $2.15 and $2.25, greater than prior guidance of $1.40 to $1.60 earnings per share. Moderna — Shares […]
Read More
Moderna to cut $1.1 billion in costs and launch 10 new products by 2027 as it charts post-Covid future
Moderna headquarters, exterior view, Cambridge, Massachusetts, USA. Plexi Images | GHI | UCG | Universal Images Group | Getty Images Moderna on Thursday said it plans to cut around $1.1 billion in expenses by 2027 and win approvals for several new products as it charts a path forward after the rapid decline of its Covid business. […]
Read More
FDA authorizes Novavax’s updated Covid vaccine, paving way for fall rollout
A vial labelled “Novavax V COVID-19 Vaccine” is seen in this illustration taken January 16, 2022. Dado Ruvic | Reuters The Food and Drug Administration authorized Novavax‘s updated protein-based Covid vaccine for emergency use in people ages 12 and up on Friday, paving the way for the shot to compete with Pfizer and Moderna‘s jabs […]
Read More
Healthy Returns: What to know about the latest round of Pfizer, Moderna Covid vaccines
Moderna Covid-19 Vaccine mRNA 2024-2025 formula. Courtesy: Moderna A version of this article first appeared in CNBC’s Healthy Returns newsletter, which brings the latest health-care news straight to your inbox. Subscribe here to receive future editions. It’s that time of the year again. A new round of Covid shots is on its way to Americans. […]
Read More
U.S. will again offer free at-home Covid tests starting in late September
Images By Tang Ming Tung | DigitalVision | Getty Images The Biden administration on Friday said it will resume offering free at-home Covid-19 tests to American households in late September as the virus has gained a stronger foothold in the U.S. this summer. Americans will soon be able to use COVIDtests.gov to request four free […]
Read More
FDA approves updated Pfizer, Moderna Covid vaccines as virus surges; shots to be available within days
The Food and Drug Administration on Thursday approved updated Covid vaccines from Pfizer and Moderna, putting the new shots on track to reach most Americans in the coming days amid a summer surge of the virus. The jabs target a strain called KP.2, a descendant of the highly contagious omicron subvariant JN.1 that began circulating […]
Read More
Healthy Returns: The race to develop combination shots targeting Covid, flu is heating up
New vaccine COMIRNATY® (Covid-19 Vaccine, mRNA) by Pfizer, available at CVS Pharmacy in Eagle Rock, California. Irfan Khan | Los Angeles Times | Getty Images A version of this article first appeared in CNBC’s Healthy Returns newsletter, which brings the latest health-care news straight to your inbox. Subscribe here to receive future editions. Good afternoon! […]
Read More
The rise of OpenAI and Microsoft’s $13 billion bet on the AI startup
OpenAI, the company behind the ChatGPT chatbot, was founded in 2015 by a number of researchers, academics and entrepreneurs, including Sam Altman, Greg Brockman and Elon Musk. Altman and Brockman are still at OpenAI, serving as CEO and president, respectively. Musk departed in 2018. At the time, OpenAI said Musk left to avoid a conflict […]
Read More
Disney and this AI stock are among the most oversold stocks this week and could be due for a bounce
The stock market clawed back from a global rout to finish higher Friday, but there still may be an opportunity for some names to rebound. Stocks had a rough start to the week. Disappointing payrolls data coupled with an unraveling of the yen “carry trade,” not to mention concerns that the Federal Reserve has waited […]
Read More
Stocks making the biggest moves midday: Shake Shack, C.H. Robinson, Mobileye Global and more
Check out the companies making headlines in midday trading: Shake Shack — The stock gained more than 15% after the burger chain’s revenue topped estimates. Shake Shack earned 27 cents per share, excluding items, on revenue of $316 million, above the LSEG estimate of $314 million. Shake Shack also narrowed its full-year revenue estimate to […]
Read More